Loading Events

« All Events

  • This event has passed.


May 6 @ 17:00 - 20:00

Welcome to Medicon Valley Alliance R&D Network and our 3rd meeting!

What can R&D learn from orphan drug development:
– The use of AI to find the right patients 
– Working closely with stakeholders

Finding the right treatment for the right patient is one major challenge within R&D. The challenges inherent in drug development in rare diseases has enforced stakeholders in this field in pioneering new ways during their R&D.

Medicon Valley Alliance, together with one of our members – Zealand Pharma – now welcomes you to the MVA R&D Network and our 3rd meeting where we will discuss lessons learned from drug development in rare diseases and how this could be applied to all drug development. Aspects like how to implement AI and how to relate to and interact with the ever-changing stakeholder landscape will be highlighted.

Date: 6 May, 2019
Time: 17:00 – 20:00
Host: Zealand Pharma A/S
Venue: Medicon Valley Alliance, Auditorium, Arne Jacobsens Alle 15 , 2300 Ørestad City, Copenhagen
Cost: Free of charge for MVA members
Sign up

The network
Medicon Valley Alliance R&D Network – an interdisciplinary network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The objective of the network is to strengthen collaboration and knowledge-sharing to stimulate that great science turns into successful innovations for the benefit of patients and society. The network is scheduled to meet twice a year.
The network is free of charge and is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate whether joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically make you able to join the Medicon Valley Alliance R&D Network.

More information to come soon

17.00 – 17.30
Registration, networking and a bite to eat

17.30 – 17.40
Petter Hartman, CEO, Medicon Valley Alliance
Camilla Westergaard Borgen, Commercial Development Director, Zealand Pharma A/S

The use of AI to find the right patients

Deploying predictive analytics for precision patient and provider finding
Oodaye Shukla, Chief Data & Analytics Officer, HVH Precision Analytics, Pennsylvania, US

AI at Lund University – ongoing activities and opportunities for academia-industry interaction
Sonja Aits, Associate Senior Lecturer, Cell Death and Lysosomes Group, Dept. of Experimental Medical Science, Lund University

Working closely with stakeholders

Early engagement with regulators to improve drug development
Steffen Thirstrup, Director, NDA Regulatory Advisory Board, former CHMP member and Division Head at the Danish Medicines Agency

Why involve patients in medical research?
Jeanette Andersen, EUPATI Patient Expert & Chair, Lupus Europe

Panel discussion
Steffen Thirstrup, Director, NDA Regulatory Advisory Board, former CHMP member and Division Head at the Danish Medicines Agency
Jeanette Andersen, EUPATI Patient Expert & Chair,Lupus Europe

Concluding remarks
Camilla Westergaard Borgen, Commercial Development Director Zealand Pharma A/S

19.30 – 19.00
Networking & refreshments

For more information please contact Senior Project Manager Helen Pettersson: hp@mva.org


May 6
17:00 - 20:00
Event Category:


Medicon Valley Alliance, Auditorium
Arne Jacobsens Allé 15
Ørestad City, 2300 Denmark
+ Google Map


Email Address
IDEON Science Park logo

Keep track of future developments with the Ideon newsletter!

You can unsubscribe in one click and we will never share your email address with third parties. .

You have Successfully Subscribed!